|Day Low/High||1.81 / 2.20|
|52 Wk Low/High||0.80 / 8.96|
These under-$10 stock look poised to break out and trade higher from current levels.
Repros Therapeutics (RPRX) stock is dropping on Tuesday after the FDA asked the company to conduct an additional Phase 3 trial of its enclomiphene drug.
These stocks trading for less than $10 a share are within range of triggering breakout trades.
The most recent short interest data has been released by the NASDAQ for the 06/15/2015 settlement date, which shows a 486,074 share increase in total short interest for Repros Therapeutics Inc , to 3,408,821, an increase of 16.63% since 05/29/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
These under-$10 biotech stocks are within range of triggering breakout trades.